November 10, 2016 07:36 AM EST
R&D

Bris­tol-My­ers scores fresh brag­ging rights with PhI­II gas­tric can­cer suc­cess for Op­di­vo

Arsalan Arif

Founder

Bris­tol-My­ers Squibb has grabbed some bad­ly need­ed new brag­ging rights in the check­point space, an­nounc­ing Thurs­day morn­ing that in­ves­ti­ga­tors reaped pos­i­tive over­all sur­vival da­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Phar­ma's wins and loss­es in Trump's sprawl­ing ex­ec­u­tive or­der on drug prices

Biotech seed rounds sink to low­est lev­el in years as in­dus­try slump drags on

Sarep­ta los­es CMO to RNA edit­ing up­start; An­oth­er wave of per­son­nel moves at Dyne

Trump pledges his sup­port for a change to the IRA long sought by drug­mak­ers

Sanofi to pay $125M up­front for two im­munol­o­gy drugs from lit­tle-known biotech

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times